Novartis sues Teva for Jadenu patent infringement

01-08-2016

Novartis sues Teva for Jadenu patent infringement

360b / Shutterstock.com

Novartis has filed a complaint against Teva claiming the Israel-based company allegedly infringed one of its patents covering the drug Jadenu (deferasirox).


Novartis, Teva, patent, Jadenu, deferasirox

LSIPR